Perihepatic nodes detected by point-of-care ultrasound in acute hepatitis and acute-on-chronic liver disease

Table 1 Nodal manifestations of variable etiologies in this study cohort, number of cases (n), gender distribution, nodal prevalence (WT ≥ 5 mm) and nodal width (WT) values (medium and mean)

Diagnosis according to etiology	n	Gender (%) male/female	WT≥5 mm (Yes/No) (%)	WT, median (Q1, Q3)	WT, mean ± SD
Viral
CHBwAE	77	64.9/35.1	77.9/22.1	6.5 (5, 8)	6.32 ± 3.245
CHCwAE	11	63.6/36.4	100/0	6.1 (5, 7)	6.79 ± 2.23
Acute A	5	60/40	100/0	13 (13, 14)	15.12 ± 7.76
Acute B	11	54.5/45.5	63.6/36.4	6.8 (4, 8.1)	6.35 ± 3.27
Acute C	6	50/50	100/0	8.15 (8, 9)	7.92 ± 1.41
Non-viral
AIH	10	20/80	50/50	4.65 (0, 7)	3.83 ± 3.51
AH	9	88.9/11.1	44.4/55.6	3.3 (0, 7.6)	3.77 ± 3.84
DILI	24	37.5/62.5	29.2/70.8	0 (0, 5.1)	2.08 ± 2.90
Infective	13	30.8/69.2	30.8/69.2	0 (0, 5.2)	2.57 ± 3.16
Ischemic	10	70/30	10/90	0 (0, 5.2)	0.90 ± 1.91

CHBwAE: Chronic B hepatitis with acute flare; CHCwAE: Chronic C hepatitis with acute flare; Acute A: Acute hepatitis A; Acute B: Acute hepatitis B; Acute C: Acute hepatitis C; AIH: Autoimmune hepatitis; AH: Alcoholic hepatitis; DILI: Drug induced liver injury; Infective: Infective hepatitis; Ischemic: Ischemic hepatitis; WT: Width.